D.E. Shaw & Co’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.67M | Sell |
389,499
-80,098
| -17% | -$879K | ﹤0.01% | 2408 |
|
|
2025
Q4 | $5.83M | Sell |
469,597
-155,554
| -25% | -$2.07M | ﹤0.01% | 2186 |
|
|
2025
Q3 | $8.96M | Sell |
625,151
-43,153
| -6% | -$591K | 0.01% | 1773 |
|
|
2025
Q2 | $8.2M | Buy |
668,304
+326,674
| +96% | +$4.74M | 0.01% | 1648 |
|
|
2025
Q1 | $7.51M | Sell |
341,630
-391,921
| -53% | -$9.22M | 0.01% | 1603 |
|
|
2024
Q4 | $16.6M | Sell |
733,551
-289,713
| -28% | -$6.32M | 0.01% | 1148 |
|
|
2024
Q3 | $18.6M | Buy |
1,023,264
+167,912
| +20% | +$3.89M | 0.02% | 1032 |
|
|
2024
Q2 | $24.9M | Buy |
855,352
+335,557
| +65% | +$9.95M | 0.02% | 778 |
|
|
2024
Q1 | $18.4M | Buy |
519,795
+107,938
| +26% | +$4.32M | 0.02% | 964 |
|
|
2023
Q4 | $17.9M | Sell |
411,857
-35,733
| -8% | -$1.41M | 0.02% | 999 |
|
|
2023
Q3 | $17.1M | Buy |
447,590
+43,922
| +11% | +$1.85M | 0.02% | 947 |
|
|
2023
Q2 | $16.6M | Buy |
403,668
+54,618
| +16% | +$2.63M | 0.02% | 980 |
|
|
2023
Q1 | $20M | Sell |
349,050
-14,743
| -4% | -$831K | 0.02% | 896 |
|
|
2022
Q4 | $20.4M | Buy |
363,793
+56,439
| +18% | +$2.87M | 0.02% | 904 |
|
|
2022
Q3 | $13M | Buy |
307,354
+3,048
| +1% | +$156K | 0.02% | 1148 |
|
|
2022
Q2 | $16.4M | Buy |
304,306
+42,826
| +16% | +$2.57M | 0.02% | 1004 |
|
|
2022
Q1 | $16.8M | Buy |
261,480
+227,936
| +680% | +$15M | 0.02% | 1156 |
|
|
2021
Q4 | $2.25M | Sell |
33,544
-12,500
| -27% | -$846K | ﹤0.01% | 3252 |
|
|
2021
Q3 | $3.15M | Sell |
46,044
-44,190
| -49% | -$3.12M | ﹤0.01% | 2578 |
|
|
2021
Q2 | $6.16M | Sell |
90,234
-47,145
| -34% | -$3.33M | 0.01% | 1874 |
|
|
2021
Q1 | $9.49M | Sell |
137,379
-65,764
| -32% | -$4.46M | 0.01% | 1391 |
|
|
2020
Q4 | $13.2M | Sell |
203,143
-129,294
| -39% | -$6.96M | 0.01% | 1209 |
|
|
2020
Q3 | $15.7M | Sell |
332,437
-52,430
| -14% | -$2.49M | 0.02% | 964 |
|
|
2020
Q2 | $18.1M | Sell |
384,867
-110,264
| -22% | -$5.42M | 0.02% | 835 |
|
|
2020
Q1 | $22.1M | Buy |
495,131
+92,553
| +23% | +$4.86M | 0.03% | 574 |
|
|
2019
Q4 | $23.5M | Sell |
402,578
-21,114
| -5% | -$1.26M | 0.03% | 735 |
|
|
2019
Q3 | $25.5M | Sell |
423,692
-6,900
| -2% | -$411K | 0.03% | 660 |
|
|
2019
Q2 | $24M | Sell |
430,592
-52,694
| -11% | -$2.71M | 0.03% | 661 |
|
|
2019
Q1 | $26.9M | Buy |
483,286
+47,297
| +11% | +$2.41M | 0.03% | 592 |
|
|
2018
Q4 | $19.7M | Sell |
435,989
-17,040
| -4% | -$935K | 0.03% | 722 |
|
|
2018
Q3 | $29.8M | Sell |
453,029
-59,730
| -12% | -$3.71M | 0.04% | 594 |
|
|
2018
Q2 | $33M | Buy |
512,759
+373,809
| +269% | +$23.1M | 0.04% | 502 |
|
|
2018
Q1 | $7.69M | Buy |
138,950
+3,899
| +3% | +$204K | 0.01% | 1149 |
|
|
2017
Q4 | $6.46M | Sell |
135,051
-8,081
| -6% | -$396K | 0.01% | 1317 |
|
|
2017
Q3 | $7.22M | Sell |
143,132
-119,690
| -46% | -$6.15M | 0.01% | 1130 |
|
|
2017
Q2 | $14.3M | Sell |
262,822
-30,393
| -10% | -$1.45M | 0.02% | 732 |
|
|
2017
Q1 | $12.4M | Buy |
293,215
+226,997
| +343% | +$9.7M | 0.02% | 794 |
|
|
2016
Q4 | $2.84M | Buy |
66,218
+43,710
| +194% | +$1.78M | ﹤0.01% | 1747 |
|
|
2016
Q3 | $929K | Sell |
22,508
-55,608
| -71% | -$2.33M | ﹤0.01% | 2426 |
|
|
2016
Q2 | $3.12M | Sell |
78,116
-71,182
| -48% | -$2.56M | 0.01% | 1608 |
|
|
2016
Q1 | $5.03M | Sell |
149,298
-22,288
| -13% | -$694K | 0.01% | 1273 |
|
|
2015
Q4 | $5.82M | Buy |
171,586
+1,738
| +1% | +$54.3K | 0.01% | 1302 |
|
|
2015
Q3 | $5.06M | Buy |
169,848
+67,747
| +66% | +$2.12M | 0.01% | 1384 |
|
|
2015
Q2 | $2.81M | Buy |
102,101
+66,121
| +184% | +$1.76M | ﹤0.01% | 1924 |
|
|
2015
Q1 | $907K | Buy |
35,980
+5,225
| +17% | +$124K | ﹤0.01% | 2642 |
|
|
2014
Q4 | $682K | Sell |
30,755
-256
| -0.8% | -$5.19K | ﹤0.01% | 3109 |
|
|
2014
Q3 | $629K | Buy |
+31,011
| New | +$617K | ﹤0.01% | 3167 |
|
|
2014
Q2 | – | Sell |
-37,558
| Closed | -$706K | – | 4343 |
|
|
2014
Q1 | $706K | Sell |
37,558
-73,304
| -66% | -$1.41M | ﹤0.01% | 3326 |
|
|
2013
Q4 | $2.16M | Buy |
+110,862
| New | +$2.03M | ﹤0.01% | 2459 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
D.E. Shaw & Co's IART Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Integra LifeSciences (IART) stake by 17% in Q1 2026, selling an estimated $879K and leaving 389,499 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.
D.E. Shaw & Co first reported a position in IART in Q4 2013 and has held it in 49 quarters since. The position peaked at $33M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- D.E. Shaw & Co held 389,499 shares of Integra LifeSciences worth $3.67M as of Q1 2026.
- D.E. Shaw & Co sold 80,098 Integra LifeSciences shares in Q1 2026, an estimated $879K.
- Integra LifeSciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2408 holding.
- D.E. Shaw & Co first reported a position in Integra LifeSciences in Q4 2013 and has held it in 49 quarters since.
- D.E. Shaw & Co's Integra LifeSciences position peaked at $33M in Q2 2018.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.